AzurRx BioPharma, Inc. (AZRX) Stock Analysis
DELISTED 2021
What happened to AzurRx BioPharma, Inc. (AZRX) stock?
AzurRx BioPharma, Inc. (AZRX) no longer trades on public markets. It was delisted in September 2021. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- September 2021
- Last recorded price (historical):
- $3.45 (last quote on record before the September 2021 delisting; historical, not a current quote)
Market cap $3.43M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
AzurRx BioPharma, Inc. (AZRX). AzurRx BioPharma, Inc. is a biotechnology company focused on developing non-systemic biologics for gastrointestinal disorders. Their pipeline includes MS1819 for exocrine pancreatic insufficiency and AZX1101 for hospital-acquired infections and antibiotic-associated diarrhea.
Last analyzed: Mar 15, 2026AzurRx BioPharma, Inc. (AZRX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy AZRX shares?
No. AZRX stopped trading on public markets in September 2021, so the shares are not available through a broker. Anything you see quoted for AZRX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AZRX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to AzurRx BioPharma, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.